Inflammatory bowel disease and risk of mortality in COPD

Patients with chronic obstructive pulmonary disease (COPD) have higher incidence and prevalence of other chronic inflammatory diseases, including inflammatory bowel disease (IBD). We assessed whether IBD onset increases mortality risk in patients with COPD or asthma-associated COPD. Two population-b...

Full description

Saved in:
Bibliographic Details
Published inThe European respiratory journal Vol. 47; no. 5; pp. 1357 - 1364
Main Authors Vutcovici, Maria, Bitton, Alain, Ernst, Pierre, Kezouh, Abbas, Suissa, Samy, Brassard, Paul
Format Journal Article
LanguageEnglish
Published England 01.05.2016
Subjects
Online AccessGet full text
ISSN0903-1936
1399-3003
1399-3003
DOI10.1183/13993003.01945-2015

Cover

Abstract Patients with chronic obstructive pulmonary disease (COPD) have higher incidence and prevalence of other chronic inflammatory diseases, including inflammatory bowel disease (IBD). We assessed whether IBD onset increases mortality risk in patients with COPD or asthma-associated COPD. Two population-based cohorts of COPD and asthma-COPD subjects were identified using the administrative health databases in Québec, Canada, 1990–2007. Death records were retrieved from the death certificate registry. Cox proportional hazards models were used to assess the impact of newly developed IBD on mortality risk. The COPD and asthma-COPD cohorts included 273 208 and 26 575 patients, respectively, of which 697 and 119 developed IBD. IBD increased the risk of all-cause mortality in both COPD (hazard ratio 1.23, 95% CI 1.09–1.4) and asthma-COPD (hazard ratio 1.65, 95% CI 1.23–2.22). In asthma-COPD patients, IBD increased the risk of mortality from respiratory conditions (hazard ratio 2.18, 95% CI 1.31–3.64); in COPD patients, IBD increased the risk of death from digestive conditions (hazard ratio 4.45, 95% CI 2.39–8.30). IBD is a risk factor for mortality in patients with pre-existing COPD or asthma-COPD. IBD increased mortality by respiratory and digestive conditions in patients with asthma-COPD and COPD, respectively.
AbstractList Patients with chronic obstructive pulmonary disease (COPD) have higher incidence and prevalence of other chronic inflammatory diseases, including inflammatory bowel disease (IBD). We assessed whether IBD onset increases mortality risk in patients with COPD or asthma-associated COPD.Two population-based cohorts of COPD and asthma-COPD subjects were identified using the administrative health databases in Québec, Canada, 1990-2007. Death records were retrieved from the death certificate registry. Cox proportional hazards models were used to assess the impact of newly developed IBD on mortality risk.The COPD and asthma-COPD cohorts included 273 208 and 26 575 patients, respectively, of which 697 and 119 developed IBD. IBD increased the risk of all-cause mortality in both COPD (hazard ratio 1.23, 95% CI 1.09-1.4) and asthma-COPD (hazard ratio 1.65, 95% CI 1.23-2.22). In asthma-COPD patients, IBD increased the risk of mortality from respiratory conditions (hazard ratio 2.18, 95% CI 1.31-3.64); in COPD patients, IBD increased the risk of death from digestive conditions (hazard ratio 4.45, 95% CI 2.39-8.30).IBD is a risk factor for mortality in patients with pre-existing COPD or asthma-COPD. IBD increased mortality by respiratory and digestive conditions in patients with asthma-COPD and COPD, respectively.Patients with chronic obstructive pulmonary disease (COPD) have higher incidence and prevalence of other chronic inflammatory diseases, including inflammatory bowel disease (IBD). We assessed whether IBD onset increases mortality risk in patients with COPD or asthma-associated COPD.Two population-based cohorts of COPD and asthma-COPD subjects were identified using the administrative health databases in Québec, Canada, 1990-2007. Death records were retrieved from the death certificate registry. Cox proportional hazards models were used to assess the impact of newly developed IBD on mortality risk.The COPD and asthma-COPD cohorts included 273 208 and 26 575 patients, respectively, of which 697 and 119 developed IBD. IBD increased the risk of all-cause mortality in both COPD (hazard ratio 1.23, 95% CI 1.09-1.4) and asthma-COPD (hazard ratio 1.65, 95% CI 1.23-2.22). In asthma-COPD patients, IBD increased the risk of mortality from respiratory conditions (hazard ratio 2.18, 95% CI 1.31-3.64); in COPD patients, IBD increased the risk of death from digestive conditions (hazard ratio 4.45, 95% CI 2.39-8.30).IBD is a risk factor for mortality in patients with pre-existing COPD or asthma-COPD. IBD increased mortality by respiratory and digestive conditions in patients with asthma-COPD and COPD, respectively.
Patients with chronic obstructive pulmonary disease (COPD) have higher incidence and prevalence of other chronic inflammatory diseases, including inflammatory bowel disease (IBD). We assessed whether IBD onset increases mortality risk in patients with COPD or asthma-associated COPD. Two population-based cohorts of COPD and asthma-COPD subjects were identified using the administrative health databases in Québec, Canada, 1990–2007. Death records were retrieved from the death certificate registry. Cox proportional hazards models were used to assess the impact of newly developed IBD on mortality risk. The COPD and asthma-COPD cohorts included 273 208 and 26 575 patients, respectively, of which 697 and 119 developed IBD. IBD increased the risk of all-cause mortality in both COPD (hazard ratio 1.23, 95% CI 1.09–1.4) and asthma-COPD (hazard ratio 1.65, 95% CI 1.23–2.22). In asthma-COPD patients, IBD increased the risk of mortality from respiratory conditions (hazard ratio 2.18, 95% CI 1.31–3.64); in COPD patients, IBD increased the risk of death from digestive conditions (hazard ratio 4.45, 95% CI 2.39–8.30). IBD is a risk factor for mortality in patients with pre-existing COPD or asthma-COPD. IBD increased mortality by respiratory and digestive conditions in patients with asthma-COPD and COPD, respectively.
Patients with chronic obstructive pulmonary disease (COPD) have higher incidence and prevalence of other chronic inflammatory diseases, including inflammatory bowel disease (IBD). We assessed whether IBD onset increases mortality risk in patients with COPD or asthma-associated COPD.Two population-based cohorts of COPD and asthma-COPD subjects were identified using the administrative health databases in Québec, Canada, 1990-2007. Death records were retrieved from the death certificate registry. Cox proportional hazards models were used to assess the impact of newly developed IBD on mortality risk.The COPD and asthma-COPD cohorts included 273 208 and 26 575 patients, respectively, of which 697 and 119 developed IBD. IBD increased the risk of all-cause mortality in both COPD (hazard ratio 1.23, 95% CI 1.09-1.4) and asthma-COPD (hazard ratio 1.65, 95% CI 1.23-2.22). In asthma-COPD patients, IBD increased the risk of mortality from respiratory conditions (hazard ratio 2.18, 95% CI 1.31-3.64); in COPD patients, IBD increased the risk of death from digestive conditions (hazard ratio 4.45, 95% CI 2.39-8.30).IBD is a risk factor for mortality in patients with pre-existing COPD or asthma-COPD. IBD increased mortality by respiratory and digestive conditions in patients with asthma-COPD and COPD, respectively.
Author Ernst, Pierre
Kezouh, Abbas
Bitton, Alain
Vutcovici, Maria
Suissa, Samy
Brassard, Paul
Author_xml – sequence: 1
  givenname: Maria
  surname: Vutcovici
  fullname: Vutcovici, Maria
– sequence: 2
  givenname: Alain
  surname: Bitton
  fullname: Bitton, Alain
– sequence: 3
  givenname: Pierre
  surname: Ernst
  fullname: Ernst, Pierre
– sequence: 4
  givenname: Abbas
  surname: Kezouh
  fullname: Kezouh, Abbas
– sequence: 5
  givenname: Samy
  surname: Suissa
  fullname: Suissa, Samy
– sequence: 6
  givenname: Paul
  surname: Brassard
  fullname: Brassard, Paul
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26869671$$D View this record in MEDLINE/PubMed
BookMark eNp9kE1LAzEQhoNU7If-AkFy9LI1k-xmN0epX4VCPeg5ZDcJRHc3NUmR_nu31nrw4FwGhucdZp4pGvW-NwhdApkDVOwGmBCMEDYnIPIiowSKEzTZT7P9eIQmRBCWgWB8jKYxvhECPGdwhsaUV1zwEiaoWva2VV2nkg87XPtP02LtolHRYNVrHFx8x97izoekWpd22PV4sX6-O0enVrXRXPz0GXp9uH9ZPGWr9eNycbvKGlaQlDHGhKoKTW2e26IkmgrgWihBcl7moGnVCG7tcA0vKkYrOlRuDK81iLouKZuh68PeTfAfWxOT7FxsTNuq3vhtlFBWvKAcOBvQqx90W3dGy01wnQo7efx2ANgBaIKPMRj7iwCRe6fy6FR-O5V7p0NK_Ek1LqnkfJ-Ccu2_2S_MMHc0
CitedBy_id crossref_primary_10_1097_CEJ_0000000000000710
crossref_primary_10_1007_s11356_022_22710_9
crossref_primary_10_3389_fimmu_2021_727485
crossref_primary_10_1093_ibd_izz182
crossref_primary_10_1016_j_annepidem_2023_10_008
crossref_primary_10_3390_ijms25074058
crossref_primary_10_7759_cureus_27599
crossref_primary_10_3389_fimmu_2020_02144
crossref_primary_10_1186_s12938_022_00987_8
crossref_primary_10_1038_s41598_024_77273_1
crossref_primary_10_1097_MCO_0000000000000780
crossref_primary_10_1155_2024_8640014
crossref_primary_10_1038_s12276_023_01099_6
crossref_primary_10_1042_CS20200886
crossref_primary_10_1096_fj_202402320R
crossref_primary_10_3389_fimmu_2023_1125260
crossref_primary_10_1016_j_rmed_2023_107499
crossref_primary_10_1007_s00011_024_01953_x
crossref_primary_10_1016_j_clinre_2024_102445
crossref_primary_10_1016_j_amjmed_2024_09_001
crossref_primary_10_1016_j_prmcm_2024_100374
crossref_primary_10_3389_fgene_2023_1256833
crossref_primary_10_1016_j_molimm_2022_03_010
crossref_primary_10_3389_fcimb_2023_1218565
crossref_primary_10_1080_19490976_2024_2414805
crossref_primary_10_1164_rccm_202206_1066TR
crossref_primary_10_2147_COPD_S449521
crossref_primary_10_1016_j_jep_2024_119068
crossref_primary_10_3390_medsci12030041
crossref_primary_10_1007_s00408_022_00581_8
crossref_primary_10_2147_COPD_S405310
crossref_primary_10_1007_s11357_024_01451_2
crossref_primary_10_1097_MD_0000000000020511
crossref_primary_10_1016_j_heliyon_2024_e30612
crossref_primary_10_1186_s12890_019_0963_y
crossref_primary_10_3748_wjg_v22_i34_7735
crossref_primary_10_1155_2021_6655380
crossref_primary_10_1111_apt_16444
crossref_primary_10_1152_japplphysiol_00783_2020
Cites_doi 10.1016/j.pupt.2009.10.014
10.1097/MIB.0000000000000162
10.1007/s11882-014-0509-6
10.1136/thoraxjnl-2014-206740
10.1183/09031936.00079414
10.1097/00005792-199372030-00003
10.1164/rccm.200611-1630OC
10.1371/journal.pmed.0030442
10.3748/wjg.v19.i40.6794
10.1378/chest.06-1074
10.1586/ecp.13.2
10.1183/09031936.00100112
10.1080/00365520600664250
10.1080/15412550802237531
10.1097/00054725-200411000-00019
10.1038/mi.2011.55
10.1053/j.gastro.2007.09.022
10.1097/MIB.0000000000000608
10.1007/s00408-008-9080-z
10.1155/2012/278495
10.1016/0895-4356(94)00234-H
10.1038/ajg.2010.252
10.1016/j.crohns.2014.02.015
10.1001/jama.2015.12319
10.1378/chest.13-0584
10.1164/rccm.200305-640OC
10.1186/1465-9921-12-127
10.1136/gut.2005.079350
10.1136/gutjnl-2014-307983
10.1097/MCP.0000000000000118
10.1183/09031936.06.00043005
10.1016/j.rmed.2007.08.014
10.1016/j.ccm.2013.09.011
10.2214/AJR.10.5353
10.1164/rccm.201007-1099OC
10.3109/15412555.2011.611200
10.1136/thoraxjnl-2012-202872
10.1183/09031936.00133805
ContentType Journal Article
Copyright Copyright ©ERS 2016.
Copyright_xml – notice: Copyright ©ERS 2016.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1183/13993003.01945-2015
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1399-3003
EndPage 1364
ExternalDocumentID 26869671
10_1183_13993003_01945_2015
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.55
.GJ
18M
1OC
2WC
31~
3O-
53G
5GY
5RE
5VS
8-1
AADJU
AAFWJ
AAYXX
AAZMJ
ABCQX
ABJNI
ABOCM
ABSQV
ACEMG
ACGFO
ACPRK
ACXQS
ADBBV
ADDZX
ADMOG
ADYFA
AENEX
AFFNX
AFHIN
AFZJQ
AIZTS
AJAOE
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CAG
CITATION
COF
CS3
DIK
E3Z
EBS
EJD
F5P
F9R
GX1
H13
INIJC
J5H
KQ8
L7B
LH4
LW6
OK1
P2P
PQQKQ
R0Z
RHI
TER
TR2
W8F
WOQ
X7M
ZE2
ZGI
ZXP
~02
CGR
CUY
CVF
ECM
EIF
NPM
RHF
7X8
ID FETCH-LOGICAL-c350t-3339a85d2f44f570d2916d9a9046741d28c96ff69665832822224ee6bd19bb723
ISSN 0903-1936
1399-3003
IngestDate Thu Sep 04 16:20:10 EDT 2025
Wed Feb 19 02:40:46 EST 2025
Thu Apr 24 22:50:46 EDT 2025
Tue Jul 01 05:40:34 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License Copyright ©ERS 2016.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c350t-3339a85d2f44f570d2916d9a9046741d28c96ff69665832822224ee6bd19bb723
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://erj.ersjournals.com/content/erj/47/5/1357.full.pdf
PMID 26869671
PQID 1786526163
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_1786526163
pubmed_primary_26869671
crossref_primary_10_1183_13993003_01945_2015
crossref_citationtrail_10_1183_13993003_01945_2015
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-05-00
20160501
PublicationDateYYYYMMDD 2016-05-01
PublicationDate_xml – month: 05
  year: 2016
  text: 2016-05-00
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle The European respiratory journal
PublicationTitleAlternate Eur Respir J
PublicationYear 2016
References 2024102023544722000_47.5.1357.7
2024102023544722000_47.5.1357.8
2024102023544722000_47.5.1357.5
2024102023544722000_47.5.1357.6
2024102023544722000_47.5.1357.9
Wolters (2024102023544722000_47.5.1357.35) 2006; 243
2024102023544722000_47.5.1357.29
2024102023544722000_47.5.1357.27
2024102023544722000_47.5.1357.28
2024102023544722000_47.5.1357.25
2024102023544722000_47.5.1357.26
2024102023544722000_47.5.1357.23
2024102023544722000_47.5.1357.24
Blanchette (2024102023544722000_47.5.1357.38) 2008; 14
2024102023544722000_47.5.1357.21
2024102023544722000_47.5.1357.22
2024102023544722000_47.5.1357.20
2024102023544722000_47.5.1357.40
Zeki (2024102023544722000_47.5.1357.37) 2011; 2011
Bujarski (2024102023544722000_47.5.1357.41) 2015; 15
2024102023544722000_47.5.1357.18
2024102023544722000_47.5.1357.19
2024102023544722000_47.5.1357.16
2024102023544722000_47.5.1357.17
2024102023544722000_47.5.1357.39
2024102023544722000_47.5.1357.36
2024102023544722000_47.5.1357.15
2024102023544722000_47.5.1357.12
2024102023544722000_47.5.1357.34
2024102023544722000_47.5.1357.13
2024102023544722000_47.5.1357.10
2024102023544722000_47.5.1357.32
2024102023544722000_47.5.1357.11
2024102023544722000_47.5.1357.33
2024102023544722000_47.5.1357.3
Bitton (2024102023544722000_47.5.1357.14) 2015; 22
2024102023544722000_47.5.1357.30
2024102023544722000_47.5.1357.4
2024102023544722000_47.5.1357.31
2024102023544722000_47.5.1357.1
2024102023544722000_47.5.1357.2
References_xml – ident: 2024102023544722000_47.5.1357.20
  doi: 10.1016/j.pupt.2009.10.014
– ident: 2024102023544722000_47.5.1357.24
  doi: 10.1097/MIB.0000000000000162
– volume: 15
  start-page: 509
  year: 2015
  ident: 2024102023544722000_47.5.1357.41
  article-title: The asthma COPD overlap syndrome (ACOS
  publication-title: Curr Allergy Asthma Rep
  doi: 10.1007/s11882-014-0509-6
– ident: 2024102023544722000_47.5.1357.5
  doi: 10.1136/thoraxjnl-2014-206740
– ident: 2024102023544722000_47.5.1357.11
  doi: 10.1183/09031936.00079414
– ident: 2024102023544722000_47.5.1357.31
  doi: 10.1097/00005792-199372030-00003
– ident: 2024102023544722000_47.5.1357.19
  doi: 10.1164/rccm.200611-1630OC
– ident: 2024102023544722000_47.5.1357.2
  doi: 10.1371/journal.pmed.0030442
– ident: 2024102023544722000_47.5.1357.10
  doi: 10.3748/wjg.v19.i40.6794
– ident: 2024102023544722000_47.5.1357.30
  doi: 10.1378/chest.06-1074
– ident: 2024102023544722000_47.5.1357.7
  doi: 10.1586/ecp.13.2
– ident: 2024102023544722000_47.5.1357.27
  doi: 10.1183/09031936.00100112
– volume: 243
  start-page: 46
  year: 2006
  ident: 2024102023544722000_47.5.1357.35
  article-title: Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up study
  publication-title: Scand J Gastroenterol Suppl
  doi: 10.1080/00365520600664250
– ident: 2024102023544722000_47.5.1357.4
  doi: 10.1080/15412550802237531
– ident: 2024102023544722000_47.5.1357.25
  doi: 10.1097/00054725-200411000-00019
– ident: 2024102023544722000_47.5.1357.9
  doi: 10.1038/mi.2011.55
– ident: 2024102023544722000_47.5.1357.33
  doi: 10.1053/j.gastro.2007.09.022
– volume: 22
  start-page: 416
  year: 2015
  ident: 2024102023544722000_47.5.1357.14
  article-title: Mortality trends in Crohn's disease and ulcerative colitis: a population-based study in Quebec, Canada
  publication-title: Inflamm Bowel Dis
  doi: 10.1097/MIB.0000000000000608
– ident: 2024102023544722000_47.5.1357.13
  doi: 10.1007/s00408-008-9080-z
– ident: 2024102023544722000_47.5.1357.23
  doi: 10.1155/2012/278495
– ident: 2024102023544722000_47.5.1357.16
  doi: 10.1016/0895-4356(94)00234-H
– ident: 2024102023544722000_47.5.1357.28
  doi: 10.1038/ajg.2010.252
– ident: 2024102023544722000_47.5.1357.34
  doi: 10.1016/j.crohns.2014.02.015
– volume: 2011
  start-page: 861926
  year: 2011
  ident: 2024102023544722000_47.5.1357.37
  article-title: The asthma-COPD overlap syndrome: a common clinical problem in the elderly
  publication-title: J Allergy (Cairo)
– ident: 2024102023544722000_47.5.1357.3
  doi: 10.1001/jama.2015.12319
– ident: 2024102023544722000_47.5.1357.32
  doi: 10.1378/chest.13-0584
– ident: 2024102023544722000_47.5.1357.21
  doi: 10.1164/rccm.200305-640OC
– ident: 2024102023544722000_47.5.1357.39
  doi: 10.1186/1465-9921-12-127
– ident: 2024102023544722000_47.5.1357.15
  doi: 10.1136/gut.2005.079350
– ident: 2024102023544722000_47.5.1357.36
  doi: 10.1136/gutjnl-2014-307983
– ident: 2024102023544722000_47.5.1357.6
  doi: 10.1097/MCP.0000000000000118
– volume: 14
  start-page: 176
  year: 2008
  ident: 2024102023544722000_47.5.1357.38
  article-title: Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population
  publication-title: J Manag Care Pharm
– ident: 2024102023544722000_47.5.1357.18
  doi: 10.1183/09031936.06.00043005
– ident: 2024102023544722000_47.5.1357.12
  doi: 10.1016/j.rmed.2007.08.014
– ident: 2024102023544722000_47.5.1357.26
  doi: 10.1016/j.ccm.2013.09.011
– ident: 2024102023544722000_47.5.1357.29
  doi: 10.2214/AJR.10.5353
– ident: 2024102023544722000_47.5.1357.17
  doi: 10.1164/rccm.201007-1099OC
– ident: 2024102023544722000_47.5.1357.40
  doi: 10.3109/15412555.2011.611200
– ident: 2024102023544722000_47.5.1357.22
  doi: 10.1136/thoraxjnl-2012-202872
– ident: 2024102023544722000_47.5.1357.8
  doi: 10.1183/09031936.00133805
– ident: 2024102023544722000_47.5.1357.1
SSID ssj0016431
Score 2.3899305
Snippet Patients with chronic obstructive pulmonary disease (COPD) have higher incidence and prevalence of other chronic inflammatory diseases, including inflammatory...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 1357
SubjectTerms Aged
Asthma - complications
Asthma - mortality
Cohort Studies
Comorbidity
Databases, Factual
Female
Humans
Incidence
Inflammation - complications
Inflammation - mortality
Inflammatory Bowel Diseases - complications
Inflammatory Bowel Diseases - mortality
Male
Middle Aged
Proportional Hazards Models
Pulmonary Disease, Chronic Obstructive - complications
Pulmonary Disease, Chronic Obstructive - mortality
Quebec
Registries
Risk Factors
Title Inflammatory bowel disease and risk of mortality in COPD
URI https://www.ncbi.nlm.nih.gov/pubmed/26869671
https://www.proquest.com/docview/1786526163
Volume 47
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1399-3003
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0016431
  issn: 0903-1936
  databaseCode: KQ8
  dateStart: 19880101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1399-3003
  dateEnd: 20240330
  omitProxy: true
  ssIdentifier: ssj0016431
  issn: 0903-1936
  databaseCode: DIK
  dateStart: 19940101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: Open access medical journals (GFMER)
  customDbUrl:
  eissn: 1399-3003
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0016431
  issn: 0903-1936
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Za9VAFB6uFcQXce91YwQfTU1mz2MRpVqqCC30LcxMJhBpE7kmKP31nslMlqu1WF9CCMm5yZzvnmXOhtArQpQDPVElXDuZMOVUokSmE9A9rNKlyaz2juLRJ3Fwwj6e8tPV6ucia6nvzJ69uLSu5H-4CteAr75K9hqcnYjCBTgH_sIROAzHf-Lxh6YChp6HQLlpf7gp4LKVNn4-mNje3PYlfp_jRPSvM06mLfnNIvC-fAM_kavvbAtipY4VPvXsydfdOJn6TNdzNsimifUkoHnnFNtDd9H2w17OvjF6a9chE3OO37h96HPachrbWAfhCcZOQtOULqVr6KcZUcQXojKjoTN1VLsZDd3M_xTpyreW8LQ96T0wSRkHFIQi0O0G2r8ptindcHB0FC1GIsVApPBEbqCbRArhZ18cfpnjT2CnDbMWx6-M_aqAyJtL3mTbpvmLozIYLMd30Z3oaeD9AJt7aOWa--jWUcyleIDUEj14QA-O6MGAHuzRg9sKT-jBdYM9eh6ik_fvjt8eJHGORmIpT7uEUpprxUtSMVZxmZYEfIIy1_B3FGBQlkTZXFSVAM-Xg4D3JiNhzglTZrkxktBHaKdpG7eLMDcVldKWhjvFGNHa5rAAltosl1qmeo3IuBKFjU3m_ayTs-IKHqzR6-mhb6HHytW3vxyXuABZ6ANcunFt_73IpBKcCHAx1uhxWPuJIBEKPlBmT673Y0_R7Rn-z9BOt-ndczBDO_NiQMwvw997lA
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inflammatory+bowel+disease+and+risk+of+mortality+in+COPD&rft.jtitle=The+European+respiratory+journal&rft.au=Vutcovici%2C+Maria&rft.au=Bitton%2C+Alain&rft.au=Ernst%2C+Pierre&rft.au=Kezouh%2C+Abbas&rft.date=2016-05-01&rft.issn=0903-1936&rft.eissn=1399-3003&rft.volume=47&rft.issue=5&rft.spage=1357&rft.epage=1364&rft_id=info:doi/10.1183%2F13993003.01945-2015&rft.externalDBID=n%2Fa&rft.externalDocID=10_1183_13993003_01945_2015
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0903-1936&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0903-1936&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0903-1936&client=summon